Early Access — free while we kick the tires
EdgarHawk

Williams Shoran R

Director

Director
2 filings analyzed · 1 company · Latest 2025-07-30

Companies

Company Buys Sells Direction
MERCANTILE BANK CORP MBWM 2 0 Net buying

Activity

July 2025
2025-07-30 MERCANTILE BANK CORP MBWM
low
Buy
200 shares
$9,457
Significance 3/10

Director Williams Shoran R bought 200 MBWM shares at $47.28; 0% success rate on 1 prior MBWM buy; stock down -10.9% from 52-week high.

Director Williams Shoran R purchased 200 shares of Mercantile Bank Corp at $47.28 on 2025-07-29, increasing his holdings by 3.9% to 5,266 shares. This is a modest transaction ($9,457.00 total value) in a modestly valued company trading at a P/E of 9.65. However, the insider's prior purchase of MBWM shares on 2025-01-31 experienced a 90-day return of -13.9%, establishing a 0% track record of well-timed purchases at this ticker. The current stock price of $46.14 is -10.9% from its 52-week high of $51.79, suggesting the director is buying after recent price declines, yet his prior similar action at this company did not produce positive subsequent returns.

February 2025
2025-02-04 MERCANTILE BANK CORP MBWM
low
Buy
123 shares
$6,061
Significance 4/10

Director Williams Shoran R bought 123 MBWM shares at $49.28 on 2025-01-31; holds 4,147 shares post-trade

Williams Shoran R, a MERCANTILE BANK CORP director, purchased 123 shares at $49.28 on 2025-01-31, increasing his stake to 4,147 shares from 4,024 shares. The purchase price of $49.28 is within the 52-week range of $33.62–$51.16, near recent resistance. At the current price of $48.67, the purchase sits just below cost, with the stock up 10.2% over the past 30 days but down 4.9% from its 52-week high. The company trades at a P/E of 9.81 with a $785.6M market cap and $19.6M net income. The transaction is modest in absolute terms ($6.1K) and represents a +3.1% increase in the director's pre-transaction holdings, suggesting routine portfolio activity rather than a major conviction signal.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access